Immunotherapy of superficial bladder cancer

A. Shapiro; D. Kadmon; W. J. Catalona; T. L. Ratliff

doi:10.1016/S0022-5347(17)53265-6

Immunotherapy of superficial bladder cancer

A. Shapiro, D. Kadmon, W. J. Catalona, T. L. Ratliff

Urology

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

There is an increasing role for immunotherapy in the treatment of superficial recurrent bladder tumors and carcinoma in situ. BCG has proved to be an effective means of intravesical immunotherapy and a considerable experience with the treatment has accumulated. Other agents such as poly I:C, OK432 and transfer factor have not proved to be as effective. Interferon has shown impressive preliminary results but needs further evaluation in larger numbers of patients before definitive conclusions can be drawn.

Original language	English (US)
Pages (from-to)	891-894
Number of pages	4
Journal	Journal of Urology
Volume	128
Issue number	5
DOIs	https://doi.org/10.1016/S0022-5347(17)53265-6
State	Published - 1982

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0022-5347(17)53265-6

Cite this

@article{f4992fd84c3e4b12874718748d9b9925,

title = "Immunotherapy of superficial bladder cancer",

abstract = "There is an increasing role for immunotherapy in the treatment of superficial recurrent bladder tumors and carcinoma in situ. BCG has proved to be an effective means of intravesical immunotherapy and a considerable experience with the treatment has accumulated. Other agents such as poly I:C, OK432 and transfer factor have not proved to be as effective. Interferon has shown impressive preliminary results but needs further evaluation in larger numbers of patients before definitive conclusions can be drawn.",

author = "A. Shapiro and D. Kadmon and Catalona, {W. J.} and Ratliff, {T. L.}",

year = "1982",

doi = "10.1016/S0022-5347(17)53265-6",

language = "English (US)",

volume = "128",

pages = "891--894",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Immunotherapy of superficial bladder cancer

AU - Shapiro, A.

AU - Kadmon, D.

AU - Catalona, W. J.

AU - Ratliff, T. L.

PY - 1982

Y1 - 1982

N2 - There is an increasing role for immunotherapy in the treatment of superficial recurrent bladder tumors and carcinoma in situ. BCG has proved to be an effective means of intravesical immunotherapy and a considerable experience with the treatment has accumulated. Other agents such as poly I:C, OK432 and transfer factor have not proved to be as effective. Interferon has shown impressive preliminary results but needs further evaluation in larger numbers of patients before definitive conclusions can be drawn.

AB - There is an increasing role for immunotherapy in the treatment of superficial recurrent bladder tumors and carcinoma in situ. BCG has proved to be an effective means of intravesical immunotherapy and a considerable experience with the treatment has accumulated. Other agents such as poly I:C, OK432 and transfer factor have not proved to be as effective. Interferon has shown impressive preliminary results but needs further evaluation in larger numbers of patients before definitive conclusions can be drawn.

UR - http://www.scopus.com/inward/record.url?scp=0020371486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020371486&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(17)53265-6

DO - 10.1016/S0022-5347(17)53265-6

M3 - Review article

C2 - 6184490

AN - SCOPUS:0020371486

SN - 0022-5347

VL - 128

SP - 891

EP - 894

JO - Journal of Urology

JF - Journal of Urology

IS - 5

ER -

Immunotherapy of superficial bladder cancer

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this